As a strategy for Pfizer acquisition over Medivation 2016.

1. How did this particular transaction fit into the broad strategy of the acquiring firm? The selling firm? 2. Was the acquisition related or unrelated to buyers operations at time of deal? If the buyer is a private firm or private equity fund, discuss whether the buyer has invested in this industry before. 3. If related, explain how they are related. 4. If unrelated, did this appear to occur because growth opportunities for the industry as a whole were not favorable or were opportunities lacking just for the individual firm studied?